Orchard Therapeutics raises $150m in Series C funding to advance gene therapies for rare diseases
Orchard Therapeutics, a leader in gene therapy specializing in rare diseases, has successfully secured $150 million through a Series C funding round. This substantial capital injection will support the advancement and commercialization of its innovative gene therapies. The funding round was led by Deerfield Management, with significant contributions from other top-tier investment firms such as […]